Biotechnology at Plymouth State University

With comparable biotech programs in New Hampshire reporting median earnings around $50,000 and the state median debt at $27,000, Plymouth State's estimated figures—$47,000 in earnings and $20,400 in debt—suggest a more modest financial outcome than its in-state peers but with notably lower borrowing. That debt-to-earnings ratio of 0.43 is manageable by conventional standards, meaning graduates would owe less than half their first-year salary, but the earnings gap compared to UNH's programs (roughly $3,000 annually) is worth noting.

The real question is whether Plymouth State's biotech program provides adequate preparation for industry or graduate school, given that similar programs nationwide cluster around the same $47,000 earnings mark. Biotech careers often require advanced degrees for meaningful salary progression, so if this bachelor's serves primarily as a stepping stone to grad school, the lower debt load actually becomes an advantage. However, if students plan to enter the workforce directly, they might find stronger launching platforms at New Hampshire's larger research universities.

For parents, the trade-off is straightforward: potentially less earning power than competing state programs, but also $6,500 less debt based on typical outcomes elsewhere in New Hampshire. The determining factor should be whether Plymouth State offers the lab experience, research opportunities, and industry connections that justify choosing it over UNH—questions the limited graduate data here can't answer.